ES2154818T3 - Nueva forma del acido (e)-3-(6-(((2,6-diclorofenil)-tio)metil)-3-(2-feniletoxi)-2-piridinil)-2-propenoico. - Google Patents

Nueva forma del acido (e)-3-(6-(((2,6-diclorofenil)-tio)metil)-3-(2-feniletoxi)-2-piridinil)-2-propenoico.

Info

Publication number
ES2154818T3
ES2154818T3 ES96914877T ES96914877T ES2154818T3 ES 2154818 T3 ES2154818 T3 ES 2154818T3 ES 96914877 T ES96914877 T ES 96914877T ES 96914877 T ES96914877 T ES 96914877T ES 2154818 T3 ES2154818 T3 ES 2154818T3
Authority
ES
Spain
Prior art keywords
piridinil
propenoic
acid
phenyletoxi
diclorofenil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96914877T
Other languages
English (en)
Inventor
Victor Witold Jacewicz
Michael Anthony Harris
Richard Keith Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of ES2154818T3 publication Critical patent/ES2154818T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBE UNA NUEVA FORMA FISICA DEL ACIDO (E) [[(2,6 PIRIDINIL] - 2 - PROPENOICO Y SU USO EN TERAPIA.
ES96914877T 1995-04-21 1996-04-02 Nueva forma del acido (e)-3-(6-(((2,6-diclorofenil)-tio)metil)-3-(2-feniletoxi)-2-piridinil)-2-propenoico. Expired - Lifetime ES2154818T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9508137.8A GB9508137D0 (en) 1995-04-21 1995-04-21 Formulation

Publications (1)

Publication Number Publication Date
ES2154818T3 true ES2154818T3 (es) 2001-04-16

Family

ID=10773317

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96914877T Expired - Lifetime ES2154818T3 (es) 1995-04-21 1996-04-02 Nueva forma del acido (e)-3-(6-(((2,6-diclorofenil)-tio)metil)-3-(2-feniletoxi)-2-piridinil)-2-propenoico.

Country Status (23)

Country Link
US (1) US6093828A (es)
EP (1) EP0821673B1 (es)
JP (1) JPH11503737A (es)
KR (1) KR19990007900A (es)
CN (1) CN1182418A (es)
AT (1) ATE198883T1 (es)
AU (1) AU707089B2 (es)
BR (1) BR9608003A (es)
CA (1) CA2218322A1 (es)
CZ (1) CZ333797A3 (es)
DE (1) DE69611670T2 (es)
DK (1) DK0821673T3 (es)
ES (1) ES2154818T3 (es)
GB (1) GB9508137D0 (es)
GR (1) GR3035494T3 (es)
HU (1) HUP9801574A3 (es)
NO (1) NO309767B1 (es)
NZ (1) NZ307493A (es)
PL (1) PL322897A1 (es)
PT (1) PT821673E (es)
TR (1) TR199701213T1 (es)
WO (1) WO1996033174A1 (es)
ZA (1) ZA963134B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602675D0 (en) * 1996-02-09 1996-04-10 Smithkline Beecham Plc Process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2119467A1 (en) * 1991-09-19 1993-04-01 Pamela Anne Chambers Pyridine compounds for treating leukotriene-related diseases
IL106156A0 (en) * 1992-06-30 1993-10-20 Smithkline Beecham Corp Pyridinyl compounds
EP0649408A4 (en) * 1992-06-30 1995-06-21 Smithkline Beecham Corp METHOD FOR THE PRODUCTION OF PHENYLTHIOMETHYLPYRIDINYLALKENOATS.
GB9313145D0 (en) * 1993-06-25 1993-08-11 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
CA2218322A1 (en) 1996-10-24
PL322897A1 (en) 1998-03-02
KR19990007900A (ko) 1999-01-25
AU5685996A (en) 1996-11-07
CN1182418A (zh) 1998-05-20
NO974840L (no) 1997-10-20
AU707089B2 (en) 1999-07-01
WO1996033174A1 (en) 1996-10-24
ATE198883T1 (de) 2001-02-15
HUP9801574A3 (en) 1998-12-28
DE69611670T2 (de) 2001-08-23
EP0821673B1 (en) 2001-01-24
DK0821673T3 (da) 2001-06-18
ZA963134B (en) 1997-02-14
NZ307493A (en) 1998-07-28
NO309767B1 (no) 2001-03-26
JPH11503737A (ja) 1999-03-30
CZ333797A3 (cs) 1999-01-13
GB9508137D0 (en) 1995-06-07
HUP9801574A2 (hu) 1998-11-30
BR9608003A (pt) 1999-01-05
EP0821673A1 (en) 1998-02-04
NO974840D0 (no) 1997-10-20
GR3035494T3 (en) 2001-05-31
US6093828A (en) 2000-07-25
PT821673E (pt) 2001-05-31
DE69611670D1 (en) 2001-03-01
TR199701213T1 (es) 1998-03-21

Similar Documents

Publication Publication Date Title
DE68920283D1 (de) Verwendung von Plasma in Veraschungsprozes.
DE69101639D1 (de) Anwendung von löslichen fluorhaltigen tensiden zur herstellung von aerosol-präparaten mit dosierter abgabe.
FI894541A (fi) Aids-laekemedel baserade pao hiv-proteasinhibitorer.
IT7923395A0 (it) N-aril-ossazolidinoni, -ossazolidintioni, -pirrolidinoni, -pirrolidine e -tiazolidinoni, loro procedimento di preparazione eloro applicazione in terapia.
DE69410209D1 (de) Faserverstärker mit effizienter Pumpleistungsverwendung
DE19975031I2 (de) Verwendung von 4-Aminosalicyls{ure als entz}ndungshemmender Wirkstoff.
LU91147I2 (fr) Pemetrexed et ses sels pharmaceutiquement acceptables.
FI864720A0 (fi) Direkt gentransmission i plasticider och mitokondrier.
BE847515A (fr) Elements stratifies a surface plane et a pouvoir absorbant, notamment pour la fabrication d'articles d'hygiene
DE69030716D1 (de) Ausgangsverstärkerstufe mit Leistungsaufnahmeverringerungseigenschaften
DE69109898D1 (de) Nassätzverfahren und -zusammensetzung.
ES2016582B3 (es) Agente ondulante del cabello.
DE68924624D1 (de) Leistungssparender NF-Leistungsverstärker.
FI911207A0 (fi) Menetelmä uuden terapeuttisesti käyttökelpoisen retinoidin valmistamiseksi
FI894792A (fi) Anordning och foerfarande foer maetning av elstroem i stoerda foerhaollanden.
ID22841A (id) Penggunaan larutan-larutan asam manonatrium iminodiasetat di dalam pembuatan asam n-fosfonometiliminodiasetat
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
ES2154818T3 (es) Nueva forma del acido (e)-3-(6-(((2,6-diclorofenil)-tio)metil)-3-(2-feniletoxi)-2-piridinil)-2-propenoico.
MX9304728A (es) Metodo mejorado para la preparacion de glucanos solubles.
IT8919140A0 (it) Metodo e apparato per la fabbricazione di corpi provvisti ad una loro estremita' di una superficie di rivoluzione con asse allineato ad un asse prefissato di detto corpo.
DE3886371D1 (de) Herstellung des hblv-virus in der hsb-2 zell-linie.
BG97851A (en) Hard dosed forms of almocalante and method for obtaining them
TR28882A (tr) Yeni 1,3-oxazin-4-one türevleri, ayni maddeyi iceren herbisidler ve ayni maddenin hazirlanmasinda kullanilan ara ürünler.
ITMI911630A1 (it) Impianto di distribuzione di trucioli cosparsi di colla, nell'ambito della fabbricazione di pannelli truciolari.
IT1247527B (it) Agente antiarteriosclerotico, sua preparazione ed uso

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 821673

Country of ref document: ES